Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis
Authors:
Open Access
- 12 June 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (45) , 79480-79490
Abstract
Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosisKeywords
This publication has 23 references indexed in Scilit:
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Ammonia and amino acid profiles in liver cirrhosis: Effects of variables leading to hepatic encephalopathyNutrition, 2015
- Important predictor of mortality in patients with end-stage liver diseaseClinical and Molecular Hepatology, 2013
- Liver cirrhosisBest Practice & Research Clinical Gastroenterology, 2011
- Complications of CirrhosisDisease-a-Month, 2008
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Evidence-Based Incorporation of Serum Sodium Concentration Into MELDGastroenterology, 2006
- Liver fibrosisJournal of Clinical Investigation, 2005
- MELD accurately predicts mortality in patients with alcoholic hepatitis†Hepatology, 2005
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973